These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39347397)

  • 21. A clinical prognostic model related to T cells based on machine learning for predicting the prognosis and immune response of ovarian cancer.
    Lin Q; Ma W; Xu M; Xu Z; Wang J; Liang Z; Zhu L; Wu M; Luo J; Liu H; Liu J; Jin Y
    Heliyon; 2024 Sep; 10(17):e36898. PubMed ID: 39296051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative analysis of bulk and single-cell RNA-seq reveals the molecular characterization of the immune microenvironment and oxidative stress signature in melanoma.
    Li Y; Jiang B; Chen B; Zou Y; Wang Y; Liu Q; Song B; Yu B
    Heliyon; 2024 Mar; 10(6):e28244. PubMed ID: 38560689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrative analysis of cancer-associated fibroblast signature in gastric cancer.
    Zhao Z; Mak TK; Shi Y; Li K; Huo M; Zhang C
    Heliyon; 2023 Sep; 9(9):e19217. PubMed ID: 37809716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive single-cell analysis reveals heterogeneity of fibroblast subpopulations in ovarian cancer tissue microenvironment.
    Ding B; Ye Z; Yin H; Hong XY; Feng SW; Xu JY; Shen Y
    Heliyon; 2024 Mar; 10(6):e27873. PubMed ID: 38533040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response.
    Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W
    Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
    Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H
    Front Immunol; 2023; 14():1213947. PubMed ID: 37965307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
    Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
    Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining three ferroptosis-based molecular subtypes and developing a prognostic risk model for high-grade serous ovarian cancer.
    Sun X; He W; Lin B; Huang W; Ye D
    Aging (Albany NY); 2024 May; 16(10):9106-9126. PubMed ID: 38795391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell dissection reveals the role of aggrephagy patterns in tumor microenvironment components aiding predicting prognosis and immunotherapy on lung adenocarcinoma.
    Sun X; Meng F; Nong M; Fang H; Lu C; Wang Y; Zhang P
    Aging (Albany NY); 2023 Dec; 15(23):14333-14371. PubMed ID: 38095634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A programmed cell death-related gene signature to predict prognosis and therapeutic responses in liver hepatocellular carcinoma.
    Gu X; Pan J; Li Y; Feng L
    Discov Oncol; 2024 Mar; 15(1):71. PubMed ID: 38466483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revolutionary multi-omics analysis revealing prognostic signature of thyroid cancer and subsequent in vitro validation of SNAI1 in mediating thyroid cancer progression through EMT.
    Jin X; Fu C; Qi J; Chen C
    Clin Exp Med; 2024 Jun; 24(1):127. PubMed ID: 38869635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer.
    Shen L; Li A; Cui J; Liu H; Zhang S
    J Ovarian Res; 2024 Apr; 17(1):82. PubMed ID: 38627854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Xu Y; Wang Y
    J Ovarian Res; 2023 Sep; 16(1):196. PubMed ID: 37730669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.
    Fu D; Zhang B; Wu S; Feng J; Jiang H
    Front Cell Dev Biol; 2023; 11():1207642. PubMed ID: 37691822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma.
    Hu D; Zhang Z; Zhang Y; Huang K; Li X
    Front Genet; 2023; 14():1137995. PubMed ID: 37007965
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors.
    Yang D; Duan MH; Yuan QE; Li ZL; Luo CH; Cui LY; Li LC; Xiao Y; Zhu XY; Zhang HL; Feng GK; Liu GC; Deng R; Li JD; Zhu XF
    J Transl Med; 2023 Sep; 21(1):586. PubMed ID: 37658364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine-learning developed an iron, copper, and sulfur-metabolism associated signature predicts lung adenocarcinoma prognosis and therapy response.
    Zhang L; Zhang X; Guan M; Zeng J; Yu F; Lai F
    Respir Res; 2024 May; 25(1):206. PubMed ID: 38745285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
    Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
    Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.